The OraQuick HIV Self-Test is an in-vitro diagnostic home-use antibody test that utilizes oral fluid to determine whether a patient has been exposed to HIV.
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to GSK5764227 (GSK’227) for the treatment of adult patients with relapsed or refractory (R/R) osteosarcoma who have ...
Zinplava ™ (bezlotoxumab) injection will be discontinued as of January 31, 2025, according to the Food and Drug Administration’s (FDA) drug shortages tracker.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback